Cargando…
Preoperative Cessation of Both Dual Anti-Platelet Agents Is Safe after 1 Year in Patients Receiving Percutaneous Coronary Intervention
OBJECTIVE: The aim of this study was to investigate the atherothrombotic and bleeding risk of discontinuing both components of dual antiplatelet therapy (DAPT) before surgery in patients with an intracoronary stent after 1 year. METHODS: We retrospectively enrolled 212 patients who received an evalu...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society of Lipidology and Atherosclerosis
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379090/ https://www.ncbi.nlm.nih.gov/pubmed/32821739 http://dx.doi.org/10.12997/jla.2020.9.2.304 |